Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2025-12-24 @ 10:44 PM
NCT ID:
NCT01580735
Eligibility Criteria:
Key Inclusion Criteria:
* Histologically or cytologically confirmed surgically unresectable locally advanced or metastatic (stage IIIB/IV) NSCLC with EGFR activating mutation.
* Measurable disease and documented disease progression following the first and immediate EGFR-TKI monotherapy.
* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.
* Adequate organ function
Key Exclusion Criteria:
* Prior therapy with a c-Met inhibitor.
* Any systemic anti-tumor treatment for NSCLC within 7 days prior to randomization.
* Major surgical procedure within 4 weeks prior to randomization
* Known symptomatic brain metastases.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT01580735
Study Brief:
Protocol Section:
NCT01580735